Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.38 EUR | +0.85% | -0.83% | +27.96% |
04-03 | Vytrus Biotech, S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Vytrus Biotech, S.A. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Business Summary
Number of employees: 35
Sales per Business
EUR in Million | 2023 | Weight | Delta |
---|---|---|---|
Plant Stem Cells
95.0
%
| 4 | 95.0 % | - |
Plant Stem Cells Services
5.0
%
| 0 | 5.0 % | - |
Sales per region
EUR in Million | 2023 | Weight | Delta |
---|---|---|---|
Spain
39.3
%
| 1 | 39.3 % | - |
International
31.5
%
| 1 | 31.5 % | - |
European Union
29.1
%
| 1 | 29.1 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Albert Jané Font
CEO | Chief Executive Officer | - | 08-12-31 |
Chief Executive Officer | - | 08-12-31 | |
Director of Finance/CFO | - | - | |
Chief Tech/Sci/R&D Officer | - | 10-12-31 | |
Sales & Marketing | - | - | |
Corporate Officer/Principal | - | 15-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 08-12-31 | |
Albert Jané Font
CEO | Chief Executive Officer | - | 08-12-31 |
Director/Board Member | - | - | |
Director/Board Member | - | 21-12-16 | |
Director of Finance/CFO | - | - | |
Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 7,115,100 | 2,751,534 ( 38.67 %) | 379,707 ( 5.337 %) | 38.67 % |
Company contact information
Vytrus Biotech SA
Sant Gaietà 121, 2nd Floor Terrassa
08221, Barcelona
+34 93 127 81 06
http://www.vytrus.comSector
Sales per region
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+27.96% | 17.4M | |
-23.12% | 234M | |
-24.59% | 65.45M |
- Stock Market
- Equities
- VYT Stock
- Company Vytrus Biotech, S.A.